Literature DB >> 19067325

Corpus callosum damage and cognitive dysfunction in benign MS.

Sarlota Mesaros1, Maria A Rocca, Gianna Riccitelli, Elisabetta Pagani, Marco Rovaris, Domenico Caputo, Angelo Ghezzi, Ruggero Capra, Antonio Bertolotto, Giancarlo Comi, Massimo Filippi.   

Abstract

Corpus callosum (CC), the largest compact white matter fiber bundle of the human brain involved in interhemispheric transfer, is frequently damaged in the course of multiple sclerosis (MS). Cognitive impairment is one of the factors affecting quality of life of patients with benign MS (BMS). The aim of this study was to investigate the relationship between the cognitive profile of BMS patients and the extent of tissue damage in the CC. Brain conventional and DT MRI scans were acquired from 54 BMS patients and 21 healthy controls. Neuropsychological tests (NPT) exploring memory, attention, and frontal lobe cognitive domains were administered to the patients. DT tractography was used to calculate the mean diffusivity (MD) and fractional anisotropy (FA) of the CC normal appearing white matter (NAWM). An index of CC atrophy was also estimated. Nine (17%) BMS patients fulfilled criteria for cognitive impairment. Compared with controls, BMS had significantly different CC diffusivity and volumetry (P < 0.001). Compared with cognitively preserved patients, those with CI had significantly higher CC lesion volume (LV) (P = 0.02) and NAWM MD (P = 0.02). The scores obtained at PASAT were significantly correlated with CC T2 LV, and NAWM FA and MD (r values ranging from -0.31 to 0.66, P values ranging from 0.04 to <0.001). Cognitive impairment in BMS is associated with the extent of CC damage in terms of both focal lesions and diffuse fiber bundle injury. MRI assessment of topographical distribution of tissue damage may represent a rewarding strategy for understanding the subtle clinical deficits of patients with BMS. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19067325      PMCID: PMC6870794          DOI: 10.1002/hbm.20692

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  64 in total

1.  A paced visual serial addition test for fMRI.

Authors:  Richard H C Lazeron; Serge A R B Rombouts; Leo de Sonneville; Frederik Barkhof; Philip Scheltens
Journal:  J Neurol Sci       Date:  2003-09-15       Impact factor: 3.181

2.  Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.

Authors:  D H Miller; F Barkhof; I Berry; L Kappos; G Scotti; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

3.  Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study.

Authors:  F J Barkhof; M Elton; J Lindeboom; M W Tas; W F Schmidt; O R Hommes; C H Polman; A Kok; J Valk
Journal:  J Neurol       Date:  1998-03       Impact factor: 4.849

4.  Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force.

Authors:  R Rudick; J Antel; C Confavreux; G Cutter; G Ellison; J Fischer; F Lublin; A Miller; J Petkau; S Rao; S Reingold; K Syndulko; A Thompson; J Wallenberg; B Weinshenker; E Willoughby
Journal:  Ann Neurol       Date:  1997-09       Impact factor: 10.422

5.  Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis.

Authors:  A D Gean-Marton; L G Vezina; K I Marton; G K Stimac; R G Peyster; J M Taveras; K R Davis
Journal:  Radiology       Date:  1991-07       Impact factor: 11.105

Review 6.  Clinical outcome measures in multiple sclerosis.

Authors:  Maria Pia Amato; Emilio Portaccio
Journal:  J Neurol Sci       Date:  2007-03-21       Impact factor: 3.181

7.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

8.  Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study.

Authors:  R A Sperling; C R Guttmann; M J Hohol; S K Warfield; M Jakab; M Parente; E L Diamond; K R Daffner; M J Olek; E J Orav; R Kikinis; F A Jolesz; H L Weiner
Journal:  Arch Neurol       Date:  2001-01

9.  fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis.

Authors:  Caterina Mainero; Francesca Caramia; Carlo Pozzilli; Angela Pisani; Isabella Pestalozza; Giovanna Borriello; Luigi Bozzao; Patrizia Pantano
Journal:  Neuroimage       Date:  2004-03       Impact factor: 6.556

Review 10.  Diffusion MRI in multiple sclerosis.

Authors:  M Rovaris; A Gass; R Bammer; S J Hickman; O Ciccarelli; D H Miller; M Filippi
Journal:  Neurology       Date:  2005-11-22       Impact factor: 9.910

View more
  37 in total

1.  Overcoming the clinical-MR imaging paradox of multiple sclerosis: MR imaging data assessed with a random forest approach.

Authors:  K Kacar; M A Rocca; M Copetti; S Sala; S Mesaros; T Stosic Opincal; D Caputo; M Absinta; J Drulovic; V S Kostic; G Comi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-11       Impact factor: 3.825

2.  Increased functional connectivity indicates the severity of cognitive impairment in multiple sclerosis.

Authors:  David J Hawellek; Joerg F Hipp; Christopher M Lewis; Maurizio Corbetta; Andreas K Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

3.  Structural integrity of callosal midbody influences intermanual transfer in a motor reaction-time task.

Authors:  Laura Bonzano; Andrea Tacchino; Luca Roccatagliata; Giovanni Luigi Mancardi; Giovanni Abbruzzese; Marco Bove
Journal:  Hum Brain Mapp       Date:  2011-02       Impact factor: 5.038

4.  Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study.

Authors:  Alvino Bisecco; Maria A Rocca; Elisabetta Pagani; Laura Mancini; Christian Enzinger; Antonio Gallo; Hugo Vrenken; Maria Laura Stromillo; Massimiliano Copetti; David L Thomas; Franz Fazekas; Gioacchino Tedeschi; Frederik Barkhof; Nicola De Stefano; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2015-04-14       Impact factor: 5.038

5.  Functional MR imaging correlates of neuropsychological impairment in primary-progressive multiple sclerosis.

Authors:  M A Rocca; G Riccitelli; M Rodegher; A Ceccarelli; A Falini; M Falautano; A Meani; G Comi; Massimo Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

6.  Corpus callosum atrophy rate in mild cognitive impairment and prodromal Alzheimer's disease.

Authors:  Sahar Elahi; Alvin H Bachman; Sang Han Lee; John J Sidtis; Babak A Ardekani
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

7.  Normal appearing white matter permeability: a marker of inflammation and information processing speed deficit among relapsing remitting multiple sclerosis patients.

Authors:  Eldar Eftekhari; Seyed-Parsa Hojjat; Rita Vitorino; Timothy J Carroll; Charles Grady Cantrell; Liesly Lee; Matthew W Taylor; Sarah A Morrow; Haddas Benhabib; Richard I Aviv; Andrea Kassner
Journal:  Neuroradiology       Date:  2017-06-16       Impact factor: 2.804

8.  Corpus callosum atrophy correlates with gray matter atrophy in patients with multiple sclerosis.

Authors:  Eric C Klawiter; Antonia Ceccarelli; Ashish Arora; Jonathan Jackson; Sonya Bakshi; Gloria Kim; Jennifer Miller; Shahamat Tauhid; Christian von Gizycki; Rohit Bakshi; Mohit Neema
Journal:  J Neuroimaging       Date:  2014-05-09       Impact factor: 2.486

9.  Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal data.

Authors:  M P Sampat; A M Berger; B C Healy; P Hildenbrand; J Vass; D S Meier; T Chitnis; H L Weiner; R Bakshi; C R G Guttmann
Journal:  AJNR Am J Neuroradiol       Date:  2009-08-20       Impact factor: 3.825

10.  The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.

Authors:  Jelena Dackovic; Tatjana Pekmezovic; Sarlota Mesaros; Irena Dujmovic; Nebojsa Stojsavljevic; Vanja Martinovic; Jelena Drulovic
Journal:  Neurol Sci       Date:  2016-05-20       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.